Affordable Access

Zonisamide improves motor function in Parkinson disease: a randomized, double-blind study.

Authors
Type
Published Article
Journal
Neurology
1526-632X
Publisher
Ovid Technologies (Wolters Kluwer) - American Academy of Neurology
Publication Date
Volume
68
Issue
1
Pages
45–50
Identifiers
PMID: 17200492
Source
Medline
License
Unknown

Abstract

Zonisamide is safe, effective and well tolerated at 25 to 100 mg/day as an adjunctive treatment in patients with Parkinson disease.

Statistics

Seen <100 times